The risk of prion protein cross-infection has focussed attention on the potential hazards of protein contamination of re-usable medical devices. This study determined the frequency of protein contamination of ProSeal™ laryngeal mask airways (PLMA) after two cleaning procedures and tested the hypothesis that the combination of hand-and machinewashing removes protein contamination more effectively than hand-washing alone. After clinical use fifty-four PLMAs were randomly allocated to be washed by hand or by hand then machine. All PLMAs were then autoclaved at 134°C for 4 minutes. After processing, each PLMA was immersed in a 1.2% solution of erythrosin B and examined for uptake of stain. The site (outer surface, bowl and edges of the cuff, airway and drain tube, finger strap) and severity (nil/mild/moderate/severe) of staining was scored by a blinded observer. There were no differences in the site or severity of staining between the two cleaning procedures. Staining was detected on 89% of PLMAs that were handwashed and 78% of PLMAs that were hand-, then machine-washed (P=0.27). When staining occurred, it was mild in 98%, moderate in 2% and was never severe. Staining was more frequent on the edge than at any other location (all comparisons: P≤0.01). The strap never had any staining. We conclude that residual contamination of PLMAs with protein deposits is common even when machine-washing is used to augment hand-washing before autoclaving. The infection risk associated with these deposits remains to be determined.
The transmissible spongiform encephalopathies are spread by infectious prion proteins and are usually fatal 1 . Routine thermal and chemical sterilization procedures do not destroy prions 2, 3 and iatrogenic transmission has been reported 4 . Microscopically, the surface of the LMA is irregular, providing suitable conditions for protein attachment 5 . A recent study showed that hand-washing with detergent, soaking in an enzymatic solution and autoclaving does not remove all protein contamination from the re-usable Classic™ and Flexible™ laryngeal mask airways 5 .
Machine-washing is frequently used to augment hand-washing and we considered that the combination of the two might reduce protein contamination. In addition, there are no published data about protein contamination of the ProSeal™ laryngeal mask airway (PLMA) 6, 7 , which has a more complex shape and might be more difficult to decontaminate. We determined the frequency of protein contamination of the PLMA and tested the hypothesis that the combination of hand-then machine-washing removes protein contamination more effectively than handwashing alone.
METHODS
Fifty-four contaminated PLMAs were randomly allocated (by opening an opaque envelope) to be washed by hand or by hand then machine prior to autoclaving. After removal from the patient, the PLMAs were immersed in sterile saline and cleaned/ autoclaved within four hours. Hand-washing involved the following steps: 1. immersion in a 10% sodium bicarbonate solution for 3 minutes; 2. scrubbing the external surfaces including the finger strap with a cloth for at least 1 minute or until all visible material was removed; 3. scrubbing the internal surfaces of the airway and drain tubes for at least 1 minute or until all visible material was removed using a soft bristled brush. Hand-washing was identical for both groups. Machine-cleaning was with an automatic washer and thermal disinfection device (Deko 260, Melbourne, Australia) and involved the following steps: 1. prewash with cold water for 2 minutes; 2. warm wash (55°C) with water and detergent (Proclean, Campbell Cleaning Technologies, Brisbane, Australia) for 3 minutes; 3. warm rinse (55°C) with water for 2 minutes; and 4. hot rinse (85°C) for 1 minute. All PLMAs from both groups were then dried at 75°C for 30 minutes (Atherton Drying Cabinet, Brisbane, Australia), packaged in porous film and autoclaved at 134°C at 206 kPa for 4 min (Horizon and Centenary Series, Atherton Machines, Brisbane, Australia). An unused size 3, 4 and 5 PLMA acted as controls.
Each PLMA was immersed in a 1.2% solution of erythrosin B (Erythrosine E127 dye; Mallinckrodt Baker Inc, Phillipsburg, NJ, U.S.A.) for 30 minutes, rinsed in water at 20°C for 1 minute and examined for uptake of stain. Erythosin B staining is sensitive to protein concentrations of 2 to 14 µg/ml 8 . An observer blinded to the mode of cleaning scored the site and severity of staining. The sites were the outer surface, bowl and the edges of the cuff, the airway and drain tube (outside and inside), and the finger strap (outside and inside). The severity was scored according to the percentage of surface area stained: nil, mild (>0-20%), moderate (>20-80%) and severe (>80-100%). In addition, the number of uses of each PLMA at the time of testing was documented. Statistical analysis was with Chi squared test.
RESULTS
The severity of staining at each site is given in Table  1 . There were no differences in the site or severity of staining between groups. Staining was detected on 89% (n=24) of PLMAs that were hand-washed and 78% (n=21) of PLMAs that were hand-and machine-washed (P=0.27). Staining was mild in 98%, moderate in 2% and was never severe. Staining occurred more frequently on the edge than at any other location (all comparisons: P≤0.01), and less frequently on the airway and drain tube than at any other location (all: comparisons P≤0.01), other than the strap, which had no staining. The frequency of staining was similar for the outer and inner surface, and for the airway and drain tube. The mean (range) number of uses was 26 and was similar between groups. There was no correlation between number of uses and the level of contamination. There was no staining on the control devices.
DISCUSSION
We found that 89% of PLMAs processed with hand-washing and autoclaving were contaminated compared with 78% when the hand-wash was supplemented with a machine-wash. Ninety-eight per cent of contamination was graded as mild. Miller et al 5 found that all classic and flexible LMAs were contaminated and 55% were graded as mild, 25% as moderate and 20% as heavy. Miller et al 5 did not define mild, moderate and heavy staining, making it difficult to claim that we had less contamination. The statistically insignificant reduction in contamination by the addition of the machine washing step (78% cf 89%, P=0.27) in our small sample is difficult to interpret. Even if a larger study demonstrated a statistically significant 11% reduction in contamination, the clinical benefit of this would be unclear as the frequency of adverse outcomes relating to protein contamination is so low. The fact that some of the PLMAs had no contamination suggests that it is possible to remove all protein contamination from the surface. Perhaps increasing the abrasiveness and/or duration of scrubbing would increase the efficacy of protein removal. Vigorous and/or prolonged scrubbing could damage the device 5 . Increasing the temperature and/or duration of autoclaving, could also damage the device.
More contamination occurred on the edges of the cuff than the external surface. This may be related to increased difficulty with cleaning the edge. Contamination occurred more frequently on the outer surface than the bowl. This is not surprising since these former surfaces have more contact with the mucosa. Miller et al 5 also found more staining on the outer surface and edges than the bowl. Staining of the airway tube, drain tube and finger strap was less common than the cuff. This may be related to the reduced area of contact with the mucosa and/or lower contact pressure. The fact that the strap, which has no direct contact with patient tissue, was not stained suggests that direct contact plays an important role in the genesis of contamination. We speculate that direct contact, combined with pressure, forces salivary and other proteins to adhere to the surface. We found that protein contamination did not increase with the number of uses, despite the possibility that microscopic wear would increase the possibility of protein adhesion. The risk of prion disease transmission from reusable LMAs is unknown. Although the frequency of prion disease is around 1 per million 2 and the number of LMA uses is around 20 million per annum, an accurate estimate of risk cannot be determined since there are no data about the frequency of LMA contamination from an infected patient, no data about the infective dose, and no data about the amount of contaminant removed or denatured with each use/cleaning/autoclave cycle. However, a worst case estimate can be derived if we assume that the frequency of contamination from an infected patient is 100%, the frequency of infection from a contami-nated LMA is 100%, that the number of LMA uses after contamination is 20, and that the infectivity does not decrease after each use. This gives 400 infections per annum, or a 1:50,000 chance of infection per LMA use. The real figure should be much lower and may even be zero, since the frequency of contamination and cross-infection will probably be much less than 100%. Also, the risk of infection should decrease with each use since the infective dose will probably be reduced with each cleaning and autoclave cycle. There are no data about how much protein is actually present on the LMA; however, based on the sensitivity of Erythrosin B staining and the severity score, the protein density on the LMA is greater than 2 µg/ml and covers less than 20% of its surface area. There is no report of prion or other infection from reusable LMAs, but prion transmission via blood 9 and oral inoculation 10 has been reported in animal models. Transmission of hepatitis C has been reported with the LMA, but was related to crossinfection from a contaminated circuit rather than a contaminated LMA 11 .
To prevent patient-to-patient transmission, it has been suggested that all patients should be screened for prion disease, or that all equipment should be disposable. The economic consequences of each of these options on the health care system would be enormous and the benefits uncertain. There is no disposable version of the PLMA, which is arguably the safest and most effective of the LMA devices. Tordoff and Scott 12 suggested that when considering the relative risks and options we should ask whether we would reuse an LMA for ourselves or our children. Work is urgently required to determine the risk of infection, so that evidence-based policies can be made. We consider that currently there is no justification for abandoning the use of clinically proven re-usable LMA devices for clinically unproven theoretical benefits of disposable LMAs.
We conclude that PLMAs are commonly contaminated with protein deposits after standard cleaning and autoclaving procedures, even when machinewashing supplements hand-washing in the removal of these deposits. The infection risk associated with these deposits remains to be determined.
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